Latest News

Global Research Nonprofit CureDuchenne Joins Pfizer to Host Free Webinar on Pfizer’s Advancement to Phase III Gene Therapy Clinical Trial

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–CureDuchenne, the leading global nonprofit focused on finding a cure for Duchenne muscular dystrophy, will co-host a free webinar with Pfizer to discuss their advancement to Phase III Clinical Trial for PF-06939926. The webinar will take place on Wednesday, March 11 at 11:00am PT/2:00pm ET and features Dr. Beth Belluscio, Pfizer Global Clinical Lead for Rare Neurological Disorders, discussing the Phase 3 study of PF-06939926, a gene therapy for Duchenne m

Source link

Related posts

Top Archaeological Stories We're Looking Forward To This 2020


Surgeon General: Take Steps to Stop Teen E-Cig Use


️Vote for ANDREW GILLUM #Florida #FLGOV ️#Election2018 Nov 6 #KeepItBlue #WinB…


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World